(Q40579506)

English

Proteasome inhibitor PS-341 down-regulates prostate-specific antigen (PSA) and induces growth arrest and apoptosis of androgen-dependent human prostate cancer LNCaP cells

scientific article published on March 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Proteasome inhibitor PS-341 down-regulates prostate-specific antigen (PSA) and induces growth arrest and apoptosis of androgen-dependent human prostate cancer LNCaP cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Takayuki Ikezoe

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Yang Yang

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Tsuyako Saito

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

H Phillip Koeffler

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Hirokuni Taguchi

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

95

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

271-275

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Proteasome inhibitors as new anticancer drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02215.X

21 January 2018

NF-kappa B as a therapeutic target in multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02215.X

21 January 2018

Molecular sequelae of proteasome inhibition in human multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02215.X

21 January 2018

Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02215.X

21 January 2018

The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02215.X

21 January 2018

Molecular biology of the androgen receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02215.X

21 January 2018

Prostate specific antigen: a decade of discovery--what we have learned and where we are going

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02215.X

21 January 2018

Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate-specific antigen enhancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02215.X

21 January 2018

Prostate-specific antigen expression is regulated by an upstream enhancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02215.X

21 January 2018

Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02215.X

21 January 2018

Preclinical and clinical evaluation of proteasome inhibitor PS-341 for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02215.X

21 January 2018

Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02215.X

21 January 2018

Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02215.X

21 January 2018

Coregulator codes of transcriptional regulation by nuclear receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02215.X

21 January 2018

How the ubiquitin-proteasome system controls transcription

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02215.X

21 January 2018

Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02215.X

21 January 2018

Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02215.X

21 January 2018

Identifiers

10.1111/J.1349-7006.2004.TB02215.X

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40579506&oldid=1903226963"